1. Home
  2. Share Market Today

SUNCLAY Dividend

Start investing in SUNCLAY

Invest Now
Dividend Yield 0.31%
Annual Dividend ₹4.50
Ex-Dividend Date Apr 02, 2026
Total no. of dividends till date 3

SUNCLAY Dividend History :

Ex-Date Dividend Type Record Date Dividend Amount Instrument Type
2026-04-02 INTERIM 2026-04-03 ₹4.5 Equity Share
2025-03-27 INTERIM 2025-03-27 ₹4.75 Equity Share
2024-04-04 INTERIM 2024-04-04 ₹5.15 Equity Share

Load More

Open FREE Demat Account

+91
Resend OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

hero_form

Popular Stocks with Dividends

Trending News about IPOs

Walmart Pushes Flipkart To Delay IPO, Focus On FY27 Profitability Goal
Walmart Pushes Flipkart To Delay IPO, Focus On FY27 Profitability Goal
Walmart-owned Flipkart is likely to postpone its initial public offering plans as the e-commerce company shifts focus towards achieving operational profitability before the end of FY27, according to people aware of the discussions.
Bagmane REIT Lists at ₹103, Up 3.66%
Bagmane REIT Lists at ₹103, Up 3.66%
Bagmane Prime Office REIT, a commercial office real estate investment trust focused on owning and managing premium Grade A+ business parks in Bengaluru. It’s portfolio comprises of 6 Grade A+ business parks spanning 20.3 million sq. ft. total area and 19.6 million sq. ft. leasable area with committed occupancy of 97.9%. They are leased to marquee multinational tenants including Google, Amazon, Nvidia, and other global technology companies.
RFBL Flexi Pack IPO Subscribed 21.47 Times on Day 3
RFBL Flexi Pack IPO Subscribed 21.47 Times on Day 3
RFBL Flexi Pack Limited's initial public offering (IPO) closed its three-day subscription window at 21.47 times overall subscription by 5:04 PM on Day 3 (May 14, 2026). The ₹35.33 crore book-build issue, priced at ₹47 to ₹50 per share, received bids for 14,40,66,000 shares against 67,11,000 shares on offer, with total applications reaching 11,075.
Goldline Pharmaceutical IPO Subscribed 840.50 Times on Day 3
Goldline Pharmaceutical IPO Subscribed 840.50 Times on Day 3
Goldline Pharmaceutical Limited's initial public offering (IPO) closed its three-day subscription window with exceptional investor interest, reaching 840.50 times overall subscription by 4:59 PM on Day 3 (May 14, 2026). The ₹11.61 crore book-build issue, priced at ₹41 to ₹43 per share, received bids for 1,53,81,06,000 shares against 18,30,000 shares on offer, with total applications reaching 1,66,522.
See More
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

  • Flat brokerage
  • Dedicated platform for F&O
  • 0 account opening charges
  • Trade on charts
  • MTF up to 4X leverage
  • 0 Transaction Cost on MFs
+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form